Browsing by Contributors Masszi, Tamas

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 5 of 5
PreviewIssue DateTitleContributor(s)
2016 NEJM Volume 375 Issue 8 August (15).pdf.jpg2016Daratumumab, Bortezomib, and Dexamethasone for Multiple MyelomaNooka, Ajay K; Masszi, Tamas; Beksac, Meral; Spicka, Ivan; Hungria, Vania; Munder, Markus; Mateos, Maria V; Mark, Tomer M; Qi, Ming; Schecter, Jordan; Amin, Himal; Qin, Xiang; Deraedt, William; Ahmadi, Tahamtan; Spencer, Andrew
2017 BJH Volume 130 Issue 24 December (10).pdf.jpg2017Ixazomib signi fi cantly prolongs progression-free survival in high-risk relapsed / refractory myeloma patientsBahlis, Nizar J; Chng, Wee-joo; Masszi, Tamas; Viterbo, Luisa; Pour, Ludek; Ganly, Peter; Palumbo, Antonio; Cavo, Michele; Langer, Christian; Pluta, Andrzej; Nagler, Arnon; Kumar, Shaji; Ben-yehuda, Dina; Rajkumar, S Vincent; San-miguel, Jesus; Berg, Deborah; Lin, Jianch
2017 JADassociation Volume 148 Issue 10 October (37).pdf.jpg2017Management of adverse events associated with ixazomib plus lenalidomide / dexamethasone in relapsed / refractory multiple myelomaKumar, Shaji; Moreau, Philippe; Hari, Parameswaran; Ludwig, Heinz; Masszi, Tamas; Roman, H
2017 BJH Volume 178 Issue 4 August (12).pdf.jpg2017Management of adverse events associated with ixazomib plus lenalidomide / dexamethasone in relapsed / refractory multiple myelomaKumar, Shaji; Moreau, Philippe; Hari, Parameswaran; Ludwig, Heinz; Masszi, Tamas; Roman, H
426.pdf.jpg29-Jan-2015Ruxolitinib versus standard therapy for the treatment of polycythemia veraVannucchi, Alessandro M; Kiladjian, Jean Jacques; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N; Pane, Fabrizio; Zachee, Pierre; Mesa, Ruben; He, Shui; Jones, Mark M; Garrett, William; Li, Jingjin; Pirron, Ulrich; Habr, Dany; Verstovsek, Srdan